|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 183.34 USD | +0.68% |
|
+0.35% | -12.36% |
| 15:16 | ICON plc Veroffentlicht Ergebnisse aus Zwei Umfragen zum Biotechnologiesektor | CI |
| 02.12. | Icon-Umfrage zeigt zunehmende Verzögerungen beim Start klinischer Studien | RE |
Hauptkonkurrenten
| Umsatz (N-1) | Nettogewinn (N-1) | EBIT-Marge (N-1) | ROE (N-1) | ROA (N-1) | Verschuldungsgrad (N-1) | ||
|---|---|---|---|---|---|---|---|
| 8.28 Mrd. | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | ||
| 7.25 Mrd. | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | ||
| 15.4 Mrd. | 8.91% | 20.12% | 33.53% | 5.12% | 3.33x | ||
| 3.81 Mrd. | -16.92% | -14.91% | -17.71% | -11.1% | 4.46x | ||
| 2.41 Mrd. | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | ||
| 2.11 Mrd. | 19.17% | 21.38% | 58.42% | 21.52% | -1.39x | ||
| 693 Mio. | -107.63% | -20.47% | - | -25.37% | 0.13x | ||
| 705 Mio. | -64.4% | -67.38% | -93.12% | -15.15% | 2.26x | ||
| 376 Mio. | -103.97% | -76.66% | - | -37.71% | -1.14x | ||
| 7.2 Mrd. | 5.84% | 14.63% | 7.8% | 3.73% | 1.93x | ||
| 1.98 Mrd. | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | ||
| 1.22 Mrd. | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | ||
| 4.05 Mrd. | 0.25% | 19.9% | 15.1% | 6.78% | 2.05x | ||
| 509 Mio. | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | ||
| 12.94 Mio. | -1’409.6% | -1’383.2% | -148.95% | - | 0.4x | ||
| 1.68 Mrd. | 14.61% | 17.14% | 13.7% | 7.12% | 1.33x | ||
| 8.55 Mio. | -2’137.48% | -2’340.29% | -70.98% | -64.03% | 1.96x | ||
| Durchschnitt | 3.39 Mrd. | -221.36% | -220.02% | -12.21% | -6.14% | 1.20x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 5.1 Mrd. | -101.34% | -94.37% | -2.17% | -3% | 1.68x |
- Börse
- Aktien
- 932242 Aktie
- Sektor ICON Public Limited Company
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















